A recent study stated that donepezil incorporated into PLGA in the presence of Pluronics F68 caused a significant dose-dependent decrease in both gene and protein expression levels of IL-1β, IL-6, GM-CSF and TNF-α in Alzheimer’s disease [34]. This evidence concerns the gene CSF2 and early-onset autosomal dominant Alzheimer disease.